Maria Lopes-Virella to Lipoproteins
This is a "connection" page, showing publications Maria Lopes-Virella has written about Lipoproteins.
Connection Strength
2.021
-
Atherogenesis and the humoral immune response to modified lipoproteins. Atherosclerosis. 2008 Oct; 200(2):239-46.
Score: 0.274
-
Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes. Atherosclerosis. 2007 Feb; 190(2):359-69.
Score: 0.237
-
The immunogenicity of modified lipoproteins. Ann N Y Acad Sci. 2005 Jun; 1043:367-78.
Score: 0.225
-
Diabetes and kidney dysfunction markedly alter the content of sphingolipids carried by circulating lipoproteins. J Clin Lipidol. 2022 Mar-Apr; 16(2):173-183.
Score: 0.178
-
Modified lipoproteins, cytokines and macrovascular disease in non-insulin-dependent diabetes mellitus. Ann Med. 1996 Aug; 28(4):347-54.
Score: 0.122
-
Modification of lipoproteins in diabetes. Diabetes Metab Rev. 1996 Apr; 12(1):69-90.
Score: 0.119
-
Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes. Atherosclerosis. 2016 Jan; 244:93-100.
Score: 0.116
-
Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease. Eur Heart J. 1993 Dec; 14 Suppl K:118-24.
Score: 0.101
-
Apolipoprotein-defined and NMR lipoprotein subclasses in the veterans affairs diabetes trial. J Diabetes Complications. 2013 Nov-Dec; 27(6):627-32.
Score: 0.099
-
Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. J Diabetes Complications. 2013 Sep-Oct; 27(5):447-53.
Score: 0.099
-
Lipoproteins and immune responses in the vascular wall and their contribution to atherosclerosis in diabetes. Metabolism. 1992 May; 41(5 Suppl 1):11-5.
Score: 0.091
-
[Metabolism of lipoproteins in diabetes mellitus]. Journ Annu Diabetol Hotel Dieu. 1987; 55-66.
Score: 0.063
-
Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness. Diabet Med. 2006 Sep; 23(9):955-66.
Score: 0.061
-
Role of simvastatin as an immunomodulator in type 2 diabetes. Diabetes Care. 2004 Apr; 27(4):908-13.
Score: 0.052
-
Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients. A longitudinal study. Diabetes. 1983 Jan; 32(1):20-5.
Score: 0.048
-
Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control. Diabetologia. 1981 Sep; 21(3):216-23.
Score: 0.043
-
Platelet lipoproteins. A comparative study with serum lipoproteins. Biochim Biophys Acta. 1976 Aug 09; 439(2):339-48.
Score: 0.031
-
Metabolism of very low- and low-density lipoproteins isolated from normolipidaemic type 2 (non-insulin-dependent) diabetic patients by human monocyte-derived macrophages. Diabetologia. 1990 May; 33(5):299-305.
Score: 0.020
-
Interaction of very-low-density lipoprotein isolated from type I (insulin-dependent) diabetic subjects with human monocyte-derived macrophages. Metabolism. 1989 Nov; 38(11):1108-14.
Score: 0.019
-
A review of the development of large-vessel disease in diabetes mellitus. Am J Med. 1988 Nov 28; 85(5A):113-8.
Score: 0.018
-
Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients. Diabetes. 1985 Nov; 34(11):1127-33.
Score: 0.004
-
New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med. 1983 Nov 30; 75(5B):67-80.
Score: 0.003